Genetic Cancer Panel

Hereditary cancer predisposition genetic testing to identify genetic mutations associated with increased cancer risk. Helps inform preventive strategies and screening recommendations for family members.

HealthScreen's genetic screening panel uses DNA analysis to identify hereditary health risks across cancer, cardiovascular, and other genetic conditions — before symptoms ever appear. The comprehensive panel covers 167 genes: 65 cancer-risk genes (breast, bowel, skin, prostate, and cancers that may affect offspring), 83 heart health genes (high cholesterol, high blood pressure, heart attack and stroke risk factors), and 19 additional health-risk genes including dystonia, hemochromatosis, and clotting disorders. Unlike consumer genetic tests (such as 23andMe), this is a clinical-grade panel powered by Eugene Labs, with results reviewed by HealthScreen's medical team including genetic counselling support. The full gene list is available at eugenelabs.com/pages/preventive-conditions-list. Positive findings enable informed lifestyle modifications to reduce risk, access to preventive medications or surgery where appropriate (e.g., enhanced screening for BRCA carriers), personalised prevention and early detection planning, and preparation for medical procedures with awareness of anaesthesia risks or clotting concerns. Three panel options are available: 65 cancer genes ($950), 83 cardiac genes ($950), or the combined 167 cancer and cardiac genes ($1,200). The test requires only a saliva sample and results are integrated into your overall HealthScreen health profile.